IGEN International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International

IGEN 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Renee who wrote (409)	8/21/1998 12:28:00 AM
From: John Zwiener	Read Replies (1) of 1025

Renee and James, your thinking parallels mine almost exactly. Plus the price of Igen is about the same as the lowest price I think the Roche license would go for. Not much risk anymore at this price, at least longer term. I think the other things going on have a good chance of making the Roche license buyout look small. Future events will eventually get the price going IMO. Quantech. Renee, I'm still trying to get info of qqqq technology and understand it's theoritical potential. I've talked with IR and had to do some talking to make it clear the info I needed to make an educated decision. I'm not sure that they really believe that their test platform is any particular leap, but instead does what other technologies do. I know that Origen technology can theorically and practically can detect single molecules. I also wanted performance data on the myoglobin test, and they were not sure that was available, so my impression is that they weren't thrilled enough to get that info out. But I'll reserve final opinion until I get the data I need. (Also, they have NO money).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next